These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 11281339

  • 21. Comparative efficacy of lisinopril and nifedipine retard in essential hypertension: a double-blind, placebo-controlled trial.
    Richardson PJ, Meany TB, Johnston GD, Kondowe G, Grimmer SF, Breckenridge AM.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S96-8. PubMed ID: 2455154
    [Abstract] [Full Text] [Related]

  • 22. Comparisons of long-term effects of lisinopril vs nifedipine vs conventional therapy in the treatment of mild-to-moderate hypertension in patients with chronic obstructive pulmonary disease.
    Lin M, Yang YF, Lee D, Chiang HT.
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jun; 57(6):392-400. PubMed ID: 8803300
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Comparative trial of lisinopril and nifedipine in mild to severe essential hypertension.
    Mörlin C, Baglivo H, Boeijinga JK, Breckenridge AM, Clement D, Johnston GD, Klein W, Kramer R, Luccioni R, Meurer KA.
    J Cardiovasc Pharmacol; 1987 Jun; 9 Suppl 3():S49-52. PubMed ID: 2442552
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T, Linjer E, Hedner T, Lanke J, De Faire U, Wester PO, Dahlöf B, Scherstén B.
    Blood Press; 2004 Jun; 13(3):137-41. PubMed ID: 15223721
    [Abstract] [Full Text] [Related]

  • 29. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Davis BR, Piller LB, Cutler JA, Furberg C, Dunn K, Franklin S, Goff D, Leenen F, Mohiuddin S, Papademetriou V, Proschan M, Ellsworth A, Golden J, Colon P, Crow R, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group.
    Circulation; 2006 May 09; 113(18):2201-10. PubMed ID: 16651474
    [Abstract] [Full Text] [Related]

  • 30. Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
    Hilleman DE, Reyes AP, Wurdeman RL, Faulkner M.
    J Hum Hypertens; 2001 Aug 09; 15(8):559-65. PubMed ID: 11494095
    [Abstract] [Full Text] [Related]

  • 31. Long-term effect of efonidipine therapy on plasma aldosterone and left ventricular mass index in patients with essential hypertension.
    Tsutamoto T, Tanaka T, Nishiyama K, Yamaji M, Kawahara C, Fujii M, Yamamoto T, Horie M.
    Hypertens Res; 2009 Aug 09; 32(8):670-4. PubMed ID: 19498438
    [Abstract] [Full Text] [Related]

  • 32. A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
    He H, Li LM, Cao WH, Sun NL, Liu MZ, Hu YH.
    Ann Hum Biol; 2005 Aug 09; 32(1):30-43. PubMed ID: 15788353
    [Abstract] [Full Text] [Related]

  • 33. Reduction of left ventricular mass by lisinopril and nifedipine in hypertensive renal transplant recipients: a prospective randomized double-blind study.
    Midtvedt K, Ihlen H, Hartmann A, Bryde P, Bjerkely BL, Foss A, Fauchald P, Holdaas H.
    Transplantation; 2001 Jul 15; 72(1):107-11. PubMed ID: 11468543
    [Abstract] [Full Text] [Related]

  • 34. Combination of lisinopril and nifedipine GITS increases blood pressure control compared with single drugs in essential hypertensive patients.
    Taddei S, Omboni S, Ghiadoni L, Caiazza A, Fogari R, Innocenti P, Porcellati C, Giovannetti R, Corradi L, Mancia G, Salvetti A.
    J Cardiovasc Pharmacol; 2003 Apr 15; 41(4):579-85. PubMed ID: 12658059
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Barzilay JI, Davis BR, Cutler JA, Pressel SL, Whelton PK, Basile J, Margolis KL, Ong ST, Sadler LS, Summerson J, ALLHAT Collaborative Research Group.
    Arch Intern Med; 2006 Nov 13; 166(20):2191-201. PubMed ID: 17101936
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
    Aznaouridis KA, Vyssoulis GP, Karpanou EA, Marinakis AG, Barbetseas JD, Zervoudaki AI, Cokkinos DV, Stefanadis CI.
    Blood Press Monit; 2007 Apr 13; 12(2):87-94. PubMed ID: 17353651
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Determinants of urinary albumin excretion reduction in essential hypertension: A long-term follow-up study.
    Pascual JM, Rodilla E, Miralles A, Gonzalez C, Redon J.
    J Hypertens; 2006 Nov 13; 24(11):2277-84. PubMed ID: 17053551
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.